MLAB's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,127.42 -- higher than 96.87% of US-listed equities with positive expected earnings growth.
With a year-over-year growth in debt of 616.55%, Mesa Laboratories Inc's debt growth rate surpasses 96.95% of about US stocks.
The volatility of Mesa Laboratories Inc's share price is greater than that of only 4.68% US stocks with at least 200 days of trading history.
If you're looking for stocks that are quantitatively similar to Mesa Laboratories Inc, a group of peers worth examining would be AMRN, SLP, TECH, ATRS, and SPSC.
MLAB's SEC filings can be seen here. And to visit Mesa Laboratories Inc's official web site, go to www.mesalabs.com.
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. It operates through three segments: Instruments, Biological Indicators, and Continuous Monitoring. The company was founded in 1982 and is based in Lakewood, Colorado.
MLAB Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Mesa Laboratories Inc. To summarize, we found that Mesa Laboratories Inc ranked in the 30th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Mesa Laboratories Inc, consider:
The business' balance sheet reveals debt to be 10% of the company's capital (with equity being the remaining amount). Approximately merely 23.59% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
The weighted average cost of capital for the company is 9. This value is greater than 72.86% stocks in the Technology sector that generate free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
COHR, IIVI, OMCL, TTGT, and ASML can be thought of as valuation peers to MLAB, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.
Lakewood, CO, July 06, 2020 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. Mesa Labs is a global technology innovator committed to solving some of the most critical quality control challenges in the pharmaceutical, healthcare, industrial safety, environmental and food and beverage industries. Mesa Labs offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments and Continuous Monitoring) to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary